Stay updated on Ubrogepant Clinical Trial

Sign up to get notified when there's something new on the Ubrogepant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ubrogepant Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes the completed Phase 3 ACHIEVE II trial evaluating ubrogepant doses against placebo for acute migraine treatment. It includes study eligibility, locations, interventions, outcome measures, results-related dates, publications, and study documents.
    Difference
    93%
    Check dated 2026-11-09T02:50:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The 403 Forbidden page now displays site revision v3.8.0 in its footer instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T02:31:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T03:23:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-19T05:26:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T02:18:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, replacing the detailed study content and documents with a minimal error page. The additions show the 403 text and a Home link, while the bulk of the study content and related metadata were removed.
    Difference
    17%
    Check dated 2026-09-21T00:31:49.000Z thumbnail image

Stay in the know with updates to Ubrogepant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ubrogepant Clinical Trial page.